RCKT$3.27

[stock_market_widget type=”card” template=”basic2″ assets=”RCKT” realtime=”true” api=”yahoo-finance”] Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) has received FDA support to continue testing an experimental treatment for Danon disease, a...